KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewell Personal Care (EPC) Notes Payables (2016 - 2025)

Edgewell Personal Care (EPC) has disclosed Notes Payables for 17 consecutive years, with $23.2 million as the latest value for Q2 2025.

  • On a quarterly basis, Notes Payables rose 8.41% to $23.2 million in Q2 2025 year-over-year; TTM through Jun 2025 was $23.2 million, a 8.41% increase, with the full-year FY2024 number at $24.5 million, up 25.64% from a year prior.
  • Notes Payables was $23.2 million for Q2 2025 at Edgewell Personal Care, down from $27.2 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $27.4 million in Q4 2021 to a low of $17.7 million in Q2 2023.
  • A 5-year average of $23.4 million and a median of $24.2 million in 2021 define the central range for Notes Payables.
  • Peak YoY movement for Notes Payables: skyrocketed 36.72% in 2021, then decreased 28.3% in 2022.
  • Edgewell Personal Care's Notes Payables stood at $27.4 million in 2021, then dropped by 8.03% to $25.2 million in 2022, then dropped by 3.97% to $24.2 million in 2023, then rose by 12.4% to $27.2 million in 2024, then dropped by 14.71% to $23.2 million in 2025.
  • Per Business Quant, the three most recent readings for EPC's Notes Payables are $23.2 million (Q2 2025), $27.2 million (Q1 2025), and $27.2 million (Q4 2024).